Literature DB >> 13590384

A new drug for petit mal epilepsy.

F T ZIMMERMAN, B B BURGEMEISTER.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapeutic use; EPILEPSY/therapy

Mesh：

Substances：

Year:  1958        PMID： 13590384     DOI： 10.1212/wnl.8.10.769

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

1.  [SUCCINIMIDES AND PREDISPOSITION TO CONVULSIONS].

Authors:  H W STEINMANN
Journal:  Dtsch Z Nervenheilkd       Date:  1965-01-25

2.  Treatment of petit mal with ethosuximide.

Authors:  K W HEATHFIELD; E C JEWESBURY
Journal:  Br Med J       Date:  1961-08-26

3.  Treatment of childhood absence epilepsy-an evidence-based answer at last!

Authors:  Jeffrey Buchhalter
Journal:  Epilepsy Curr       Date:  2011-01       Impact factor: 7.500

4.  Criminal Minds: Cav3.2 Channels Are the Culprits, but NMDAR Are the Co-Conspirators.

Authors:  Huong Ha; John Huguenard
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

5.  [Studies on the effect of ethosuximide on the central nervous system].

Authors:  I Kästner; F Klingberg; M Müller
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1968

6.  [Catamnestic studies on pyknolepsy].

Authors:  W Kuhlo
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1965-11-22

7.  The Cognitive Profile of Ethosuximide in Children.

Authors:  Dominique M IJff; Tamar M van Veenendaal; Mariette H Debeij-van Hall; Jacobus F A Jansen; Anton J A de Louw; Marian H J M Majoie; Albert P Aldenkamp
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

8.  Current and emerging treatments for absence seizures in young patients.

Authors:  Pascal Vrielynck
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-15       Impact factor: 2.570

9.  Synaptic Changes in AMPA Receptor Subunit Expression in Cortical Parvalbumin Interneurons in the Stargazer Model of Absence Epilepsy.

Authors:  Nadia K Adotevi; Beulah Leitch
Journal:  Front Mol Neurosci       Date:  2017-12-22       Impact factor: 5.639

10.  Targeting Neural Synchrony Deficits is Sufficient to Improve Cognition in a Schizophrenia-Related Neurodevelopmental Model.

Authors:  Heekyung Lee; Dino Dvorak; André A Fenton
Journal:  Front Psychiatry       Date:  2014-02-14       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.